INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人:
CHENE, ARNAUD,GAMAIN, BENOIT,GANGNARD, STEPHANE
申请号：
CA3008192
公开号：
CA3008192A1
申请日:
2016.12.15
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention generally relates to an immunogenic construct,useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism,to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
